Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.

Mezoff E, Mann EA, Hart KW, Lindsell CJ, Cohen MB.

J Pediatr Gastroenterol Nutr. 2011 Apr;52(4):437-41. doi: 10.1097/MPG.0b013e3181f97209.

2.

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Nelson RL, Kelsey P, Leeman H, Meardon N, Patel H, Paul K, Rees R, Taylor B, Wood E, Malakun R.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD004610. doi: 10.1002/14651858.CD004610.pub4. Review. Update in: Cochrane Database Syst Rev. 2017 Mar 03;3:CD004610.

PMID:
21901692
3.

A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.

Parmar SR, Bhatt V, Yang J, Zhang Q, Schuster M.

J Oncol Pharm Pract. 2014 Jun;20(3):172-82. doi: 10.1177/1078155213490004. Epub 2013 Jun 26.

PMID:
23804627
4.

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Nelson R.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004610. Review. Update in: Cochrane Database Syst Rev. 2011;(9):CD004610.

PMID:
17636768
5.

Managing Clostridium difficile in inflammatory bowel disease (IBD).

Hashash JG, Binion DG.

Curr Gastroenterol Rep. 2014;16(7):393. doi: 10.1007/s11894-014-0393-1. Review.

PMID:
24838421
6.

Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.

Pépin J, Valiquette L, Gagnon S, Routhier S, Brazeau I.

Am J Gastroenterol. 2007 Dec;102(12):2781-8. Epub 2007 Sep 26.

PMID:
17900327
7.

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Bricker E, Garg R, Nelson R, Loza A, Novak T, Hansen J.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004610. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD004610.

PMID:
15674956
8.

Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.

Nomura K, Fujimoto Y, Yamashita M, Morimoto Y, Ohshiro M, Sato K, Oyake T, Kowata S, Konishi H, Yoshikawa T, Ishida Y, Taniwaki M; Japan Hematology/Oncology Study (J-HOST) Group Kyoto.

Scand J Gastroenterol. 2009;44(1):74-8. doi: 10.1080/00365520802321238.

PMID:
18781540
9.

Clostridium difficile-associated diarrhea and colitis.

Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr.

Infect Control Hosp Epidemiol. 1995 Aug;16(8):459-77. Review.

PMID:
7594392
10.

Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.

Hourigan SK, Chirumamilla SR, Ross T, Golub JE, Rabizadeh S, Saeed SA, Elson CO, Kelly CP, Carroll KC, Oliva-Hemker M, Sears C.

Inflamm Bowel Dis. 2013 Dec;19(13):2744-52. doi: 10.1097/01.MIB.0000435434.53871.36.

PMID:
24145927
11.

Past, present, and future therapies for Clostridium difficile-associated disease.

Surowiec D, Kuyumjian AG, Wynd MA, Cicogna CE.

Ann Pharmacother. 2006 Dec;40(12):2155-63. Epub 2006 Dec 5. Review.

PMID:
17148650
12.

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D.

CMAJ. 2004 Aug 31;171(5):466-72.

13.

Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.

Wultańska D, Banaszkiewicz A, Radzikowski A, Obuch-Woszczatyński P, Młynarczyk G, Brazier JS, Pituch H, van Belkum A.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1265-70. doi: 10.1007/s10096-010-0997-9. Epub 2010 Jun 26.

14.

Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore.

Koh TH, Tan AL, Tan ML, Wang G, Song KP.

Pathology. 2007 Aug;39(4):438-42.

PMID:
17676487
15.

Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.

Pépin J, Routhier S, Gagnon S, Brazeau I.

Clin Infect Dis. 2006 Mar 15;42(6):758-64. Epub 2006 Feb 7.

PMID:
16477549
16.

Failure of single-toxin assays to detect clostridium difficile infection in pediatric inflammatory bowel disease.

Markowitz JE, Brown KA, Mamula P, Drott HR, Piccoli DA, Baldassano RN.

Am J Gastroenterol. 2001 Sep;96(9):2688-90.

PMID:
11569696
17.
18.

Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.

Kim J, Pai H, Seo MR, Kang JO.

J Korean Med Sci. 2011 Oct;26(10):1258-64. doi: 10.3346/jkms.2011.26.10.1258. Epub 2011 Oct 1.

19.

Effect of telephoned notification of positive Clostridium difficile test results on the time to the ordering of antimicrobial therapy.

Verdoorn BP, Orenstein R, Wilson JW, Estes LL, Wendt RF, Schleck CD, Harmsen WS, Nyre LM, Patel R.

Infect Control Hosp Epidemiol. 2008 Jul;29(7):658-60. doi: 10.1086/589586.

PMID:
18518668
20.

Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Nitzan O, Elias M, Chazan B, Raz R, Saliba W.

World J Gastroenterol. 2013 Nov 21;19(43):7577-85. doi: 10.3748/wjg.v19.i43.7577. Review.

Supplemental Content

Support Center